News
Wedlake Bell advises the shareholders of Katalyst Diagnostics on the sale of Katalyst to Cruinn Diagnostics
Katalyst Diagnostics is a UK-based point-of-care diagnostics business specialising in premium and innovative diagnostic solutions for healthcare organizations and clinical professionals, providing access to advanced point-of-care technologies in areas including haematology, clinical chemistry and antipsychotic drug monitoring. Katalyst Diagnostics supports